Tattoo; Pigmentation
7
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy
Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos
Tattoo Particles: Picosecond Laser Versus Nanosecond Laser
Lutronic PicoPlus Exploratory Clinical Trial
Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects
Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer
Clinical Study to Evaluate the Performance of the PicoWayTM 1064 nm/ 785 nm/ 532nm Picosecond Laser for Tattoo Removal